Skip to main content

Correction: Screening strategies and laboratory assays to support Plasmodium falciparum histidine-rich protein deletion surveillance: where we are and what is needed

The Original Article was published on 24 June 2022

Correction: Malaria Journal (2022) 21:201 https://doi.org/10.1186/s12936-022-04226-2

Following publication of the original article [1], the authors requested the following corrections:

  • Page 6 (of the PDF)—This sentence needs revision: “In addition to pfhrp2/3, the three assays published to date target different parasite genes: pfldh [37], pfrnr2e2 [38], and cytb [39]”. In this sentence, change “cytb” to “pfbtub”.

  • Page 6 (of the PDF)—This sentence needs revision: “While pfldh and pfrnr2e2 are single-copy genes, cytb, (like the 18S rRNA gene which has 4–8 copies/genome), is a multicopy gene (30–100 copies per genome) [40] and is expressed in the P. falciparum mitochondria.”. This should be split into two sentences, and should read: “The pfldh, pfrnr2e2, and pfbtub genes are all single-copy which make them the most appropriate as references for reporting pfhrp2/3 genotype. Genes like cytb (similar to the 18S rRNA gene, which has 4–8 copies/genome), is a multicopy gene (30–100 copies per genome) [40] and is expressed in the P. falciparum mitochondria.”

  • Page 6 (of the PDF)—Table 2. Within the table in the second row, the parasite reference gene is listed as ‘pfcytb’ and internal control is ‘Parasite pfbtub’. The reference gene should be listed as ‘Parasite pfbtub’ and internal control as ‘None’.

Reference

  1. Beshir KB, Parr JB, Cunningham J, Cheng Q, Rogier E. Screening strategies and laboratory assays to support Plasmodium falciparum histidine-rich protein deletion surveillance: where we are and what is needed. Malar J. 2022;21:201. https://doi.org/10.1186/s12936-022-04226-2.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric Rogier.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Beshir, K.B., Parr, J.B., Cunningham, J. et al. Correction: Screening strategies and laboratory assays to support Plasmodium falciparum histidine-rich protein deletion surveillance: where we are and what is needed. Malar J 21, 266 (2022). https://doi.org/10.1186/s12936-022-04281-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12936-022-04281-9